Comment on: "Cell therapy for heart disease: Trial sequential analyses of two cochrane reviews"
- PMID: 27727441
- DOI: 10.1002/cpt.536
Comment on: "Cell therapy for heart disease: Trial sequential analyses of two cochrane reviews"
Abstract
Trial Sequential Analysis (TSA) is a frequentist method to help researchers control the risks of random errors in meta-analyses.1 Fisher et al.2 used TSA on cell therapy for heart diseases. The present article discusses the usefulness of TSA and its dependence on the choice of the parameters for calculation of the required information size and the adjacent monitoring boundaries, and comments on the approach by Fisher et al.2.
© 2016 ASCPT.
Comment on
-
Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews.Clin Pharmacol Ther. 2016 Jul;100(1):88-101. doi: 10.1002/cpt.344. Epub 2016 May 9. Clin Pharmacol Ther. 2016. PMID: 26818743
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
